All Stories

  1. Factors influencing the development and implementation of a prehabilitation program for kidney transplant candidates: A mixed-methods contextual analysis
  2. Low Dietary Iodine Intake and Sex-Specific Mortality in Kidney Transplant Recipients
  3. Intra-erythrocyte creatine, plasma creatine and long-term outcomes in stable kidney transplant recipients: Results from the TransplantLines Biobank and Cohort study
  4. Patient-reported Outcome Measures in Solid Organ Transplant Recipients: Current use, Challenges, and Recommendations for Future use
  5. Symptom Burden and Patient-Reported Outcomes in Kidney Transplant Recipients: Results From the TransplantLines Biobank and Cohort Studies
  6. Plasma creatine, estimated intramuscular creatine and risk of mortality in stable kidney transplant recipients: Results from the TransplantLines biobank and cohort study
  7. Urinary endotrophin as a biomarker for T cell–mediated rejection-associated fibrogenesis in kidney transplant recipients
  8. Editorial: Living Well After Organ Transplantation
  9. TransplantLines, a biobank and cohort study of solid organ transplant recipients and donors
  10. Insights Into Health-Related Quality of Life of Kidney Transplant Recipients: A Narrative Review of Associated Factors
  11. Insights in Cellular and Molecular Signatures of the Small Intestinal Graft Posttransplantation: Successful, Recovered, and Rejected—A Case Series
  12. Fatigue across different chronic kidney disease populations: experiences and needs of patients
  13. Insights into effective fatigue reducing interventions in kidney transplant candidates: a scoping review
  14. Muscle Mass, Muscle Strength, and Health-Related Quality of Life in Kidney Transplant Recipients
  15. The Effect of Health Literacy Interventions on Self-management in Chronic Diseases: A Systematic Review
  16. Validity of the Skin and UV Neoplasia Transplant Risk Assessment Calculator (SUNTRAC) tool in a Dutch cohort of transplant recipients
  17. Iron deficiency, anemia, and patient-reported outcomes in kidney transplant recipients
  18. Plasma symmetric dimethylarginine and kidney graft function in kidney transplant recipients
  19. Ethical and Legal Aspects of Organ Donation and Transplantation
  20. ‘Effects of a home-based bimodal lifestyle intervention in frail patients with end-stage liver disease awaiting orthotopic liver transplantation’: study protocol of a non-randomised clinical trial
  21. Health-related quality of life is linked to the gut microbiome in kidney transplant recipients
  22. The self-regulation skills instrument in transplantation (SSIt): Development and measurement properties of a self-report self-management instrument
  23. Exercise as a therapeutic intervention in chronic kidney disease: are we nearly there yet?
  24. Proton Pump Inhibitor Use, Fatigue, and Health-Related Quality of Life in Kidney Transplant Recipients: Results From the TransplantLines Biobank and Cohort Study
  25. European Society of Organ Transplantation (ESOT) Consensus Statement on Prehabilitation for Solid Organ Transplantation Candidates
  26. Sleep quality, fatigue, societal participation and health-related quality of life in kidney transplant recipients: a cross-sectional and longitudinal cohort study
  27. PREhabilitation of CAndidates for REnal Transplantation (PreCareTx) study: protocol for a hybrid type I, mixed method, randomised controlled trial
  28. Prehabilitation in Adult Solid Organ Transplant Candidates
  29. Hand dexterity, daily functioning and health-related quality of life in kidney transplant recipients
  30. Employment Status and Work Functioning among Kidney Transplant Recipients
  31. 342.4: Inadequate Iodine Intake and Long-term Outcomes After Kidney Transplantation
  32. Decreased haemoglobin levels are associated with lower muscle mass and strength in kidney transplant recipients
  33. Long-term cognitive impairments in kidney transplant recipients: impact on participation and quality of life
  34. Nurse-led self-management support after organ transplantation—protocol of a multicentre, stepped-wedge randomized controlled trial
  35. Plasma Lead Concentration and Risk of Late Kidney Allograft Failure: Findings From the TransplantLines Biobank and Cohort Studies
  36. Airflow Limitation, Fatigue, and Health-Related Quality of Life in Kidney Transplant Recipients
  37. Frailty and Kidney Transplantation: A Systematic Review and Meta-analysis
  38. Discrepancy between self‐perceived mycophenolic acid‐associated diarrhea and stool water content after kidney transplantation
  39. Health items with a novel patient-centered approach provided information for preference-based transplant outcome measure
  40. Health-Related Quality of Life in Solid Organ Transplant Recipients With vs Without Keratinocyte Carcinoma
  41. Rationale and design of TransplantLines: a prospective cohort study and biobank of solid organ transplant recipients
  42. Trajectories of Anxiety and Depression After Liver Transplantation as Related to Outcomes During 2-Year Follow-Up
  43. Trajectories of anxiety and depression in liver transplant candidates during the waiting-list period
  44. A prospective cohort study on posttraumatic stress disorder in liver transplantation recipients before and after transplantation: Prevalence, symptom occurrence, and intrusive memories
  45. Opinions of Dutch Liver Transplant Recipients on Anonymity of Organ Donation and Direct Contact With the Donors Family
  46. Prevalence of psychological problems and associated transplant-related variables at different time periods after liver transplantation
  47. Shared decision making in transplantation: How patients see their role in the decision process of accepting a donor liver
  48. Functioning assessment vs. conventional medical assessment: a comparative study on health professionals' clinical decision-making and the fit with patient's own perspective of health
  49. Validation of the Dutch version of the transplant effects questionnaire in liver transplant recipients
  50. Design of a Randomised Controlled Trial (RCT) on the effectiveness of a Dutch patient advocacy case management intervention among severely disabled Multiple Sclerosis patients
  51. Reasons for readmission in heart failure: Perspectives of patients, caregivers, cardiologists, and heart failure nurses
  52. Do Patients With Heart Failure Need a Case Manager?